Pharmaceutical News and Articles

Supreme Court to Decide on South Carolina's Bid to Cut Funding for Planned Parenthood

In a pivotal move, the United States Supreme Court announced Wednesday that it will review South Carolina s controversial decision to cut off state funding for

What's the Link Between Memory Problems and Sexism?

Sexism is incredibly toxic to women s lives, resulting in lower pay, fewer career opportunities, worse health care and a greater risk of violence. It also can b

Not Just Blabber: What Baby's First Vocalizations and Coos Can Tell Us

A baby s gentle murmurs and coos can melt even the stoniest heart. But those giggles and babbles are more than just music to a doting parent s ears. These vocal

Norovirus Sickens Hundreds on Three Cruise Ships: CDC

Just over 300 people have been sickened in norovirus outbreaks on three different cruise ships in December, new government data shows. This is the only month th

Check Your Pantry, Lay's Classic Potato Chips Recalled Due to Milk Allergy Risk

Holy chip Frito-Lay has issued a limited recall of select 13-oz bags of Lay s Classic Potato Chips due to the potential presence of undeclared milk, which could

FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome

Sapience Therapeutics Receives FDA Orphan Drug Designation for ST316, a First-in-Class β-catenin Antagonist, for the Treatment of Familial Adenomatous Polyposis (FAP)

TARRYTOWN, N.Y., December 19, 2024 Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide thera

Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia

Nurix Therapeutics, Inc. (Nasdaq NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with

FDA Approves Ensacove (ensartinib) for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

FDA Approves Ryoncil (remestemcel-L-rknd) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft Versus Host Disease